For laboratory research use only · Not for human consumption
R3tatrutide
10mg · Vial
Researched for weight and metabolic health.
Strength
£79.99per vial · incl. VAT
1
COA verified
Kit included
Discreet packaging
About this compound
Triple agonist at GIP, GLP-1 and glucagon receptors investigated for glucose homeostasis and adiposity.
Supplied as sterile lyophilised powder in a sealed vial with an inert stopper. Handle in a laminar-flow environment and follow institutional biosafety protocols.
Composition & handling
- Ingredients
- 10mg of R3tatrutide as lyophilised peptide; mannitol carrier where applicable. No preservatives or fillers.
- Serving size
- 1 vial per research protocol. Reconstitute with bacteriostatic water prior to use.
- Dosage
- Refer to peer-reviewed literature for your specific study design. Use the reconstitution & dosage calculator above to work out volume per dose based on your reconstitution volume.
- Storage
- Store lyophilised at -20°C. Reconstituted: 2–8°C.
- Warning
- Research use only. Not for human consumption. Not a licensed medicine.
Specifications
- Molecular formula
- C₂₂₆H₃₄₈FN₄₈O₆₈
- Sequence
- 39-aa modified peptide
- Purity (HPLC)
- ≥ 99.3%
- Strength
- 10mg
- Format
- Vial
- Storage
- Store lyophilised at -20°C. Reconstituted: 2–8°C.
- CAS lot
- Batch-specific — see COA
Related compounds
Vial
Tirzepatide
Researched for appetite and glucose regulation.
£69.99 / 10mg COA
Vial
Cagrilintide
Researched for satiety and appetite regulation.
£74.99 / 10mg COA
Pen
BestsellerR3tatrutide Pen
Pre-filled pen — GIP/GLP-1/glucagon triple agonist research.
£199.99£169.99 / 40mg COA
Pen
Tirzepatide Pen
Pre-filled pen — dual GIP/GLP-1 agonist research.
£134.99 / 40mg COA
R3tatrutide · 10mg
£79.99